J&J Vaccine 85% Efficacious Against Severe COVID Globally
Despite a lower overall efficacy vs the mRNA vaccines, officials point out the Janssen vaccine prevented most severe disease and all hospitalizations and deaths in the first Phase 3 results and is 72% efficacious against moderate-to-severe illness in the US. Medscape Medical News